JOSEF FINSTERER, MD, PHD*, MARLIES FRANK, MD. Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low. Innovative Journal of Medical and Health Sciences, [S. l.], v. 10, n. 06, p. 959–960, 2020. Disponível em: https://innovativejournal.in/index.php/ijmhs/article/view/2988. Acesso em: 3 jul. 2024.